Novo Nordisk (NVO) hits record highs as study shows Wegovy treatment cut the risk of heart issues by 20%
Go back to Novo Nordisk (NVO) hits record highs as study shows Wegovy treatment cut the risk of heart issues by 20%| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1125.25 -24.11 (2.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1149.36 | 52 Week High | $88.16 | |||
| Open | $1133.00 | 52 Week Low | $67.88 | |||
| Day High | $1134.53 | P/E | 260.47 | |||
| Day Low | $1113.55 | EPS | $4.32 | |||
| Volume | 714,402 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 45.37 -1.23 (2.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.60 | 52 Week High | $59.00 | |||
| Open | $45.58 | 52 Week Low | $32.80 | |||
| Day High | $45.91 | P/E | N/A | |||
| Day Low | $45.31 | EPS | $0.00 | |||
| Volume | 3,557,929 | |||||
